These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18624999)
21. Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity. Barbieri M; Bonafè M; Rizzo MR; Ragno E; Olivieri F; Marchegiani F; Franceschi C; Paolisso G Exp Gerontol; 2004 Jul; 39(7):1095-100. PubMed ID: 15236769 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of thyroid-associated ophthalmopathy: comparative study between prednisone and COP therapy]. Min HY; Liu XP; Jiang RX; Lian L; Hu TS Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):781-5. PubMed ID: 16191342 [TBL] [Abstract][Full Text] [Related]
23. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Hiromatsu Y; Mukai T; Kaku H; Miyake I; Ichimura M; Fukutani T; Nakayama H; Takata K; Imamura Y; Shoji S; Yamada K; Koda Y; Bednarczuk T Diabet Med; 2006 Feb; 23(2):211-5. PubMed ID: 16433722 [TBL] [Abstract][Full Text] [Related]
24. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs. Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636 [TBL] [Abstract][Full Text] [Related]
25. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160 [TBL] [Abstract][Full Text] [Related]
26. Direct orbital manometry in patients with thyroid-associated orbitopathy. Riemann CD; Foster JA; Kosmorsky GS Ophthalmology; 1999 Jul; 106(7):1296-302. PubMed ID: 10406609 [TBL] [Abstract][Full Text] [Related]
27. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy? Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277 [TBL] [Abstract][Full Text] [Related]
28. Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians. Ji-Rong Y; Bi-Rong D; Chang-Quan H; Zhen-Chan L; Hong-Mei W; Yan-Ling Z; Mattis TA Arch Med Res; 2009 Jul; 40(5):411-5. PubMed ID: 19766907 [TBL] [Abstract][Full Text] [Related]
29. The role of genetics in Graves' disease and thyroid orbitopathy. Kim N; Hatton MP Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794 [TBL] [Abstract][Full Text] [Related]
30. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967 [TBL] [Abstract][Full Text] [Related]
31. Eye muscle force development in thyroid-associated ophthalmopathy in different stages of disease. Tian S; Bolzani R; Benassi M; Lennerstrand G Acta Ophthalmol Scand; 2007 Jun; 85(4):431-7. PubMed ID: 17559468 [TBL] [Abstract][Full Text] [Related]
32. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy]. Yi WS; Xu XL Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847 [TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine. Lee BC; Doo HK; Ahn SY; Byun SH; Kim SI; Park HK; Hong M; Ha E; Yim SV; Yin C; Leem KH; Ahn YM Neurol Res; 2007; 29 Suppl 1():S32-7. PubMed ID: 17359638 [TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients. Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of orbital decompression in treatment of thyroid-associated ophthalmopathy: long-term follow-up of 78 patients. Jernfors M; Välimäki MJ; Setälä K; Malmberg H; Laitinen K; Pitkäranta A Clin Endocrinol (Oxf); 2007 Jul; 67(1):101-7. PubMed ID: 17466006 [TBL] [Abstract][Full Text] [Related]
36. [The endocrinological management of thyroid associated orbitopathy in relation to severity and activity of the disease]. Michałek K; Waśko R; Sowiński J Przegl Lek; 2004; 61(8):838-40. PubMed ID: 15789911 [TBL] [Abstract][Full Text] [Related]
37. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109 [TBL] [Abstract][Full Text] [Related]
38. [The level of cotinine - marker of tobacco smoking, in patients with hyperthyroidism]. Czarnywojtek A; Zgorzalewicz-Stachowiak M; Florek E; Piekoszewski W; Warmuz-Stangierska I; Kulińska-Niedziela I; Komar-Rychlicka K; Sowiński J Endokrynol Pol; 2006; 57(6):612-8. PubMed ID: 17253434 [TBL] [Abstract][Full Text] [Related]
39. The common variants of E-selectin gene in Graves' disease. Chen H; Cui B; Wang S; Zhao Z; Sun H; Gu X; Zhao Y; Li X; Ning G Genes Immun; 2008 Mar; 9(2):182-6. PubMed ID: 18094708 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. Kvetny J; Puhakka KB; Røhl L Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]